Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Spend Life Wisely

Ranger Micro Cap Fund Investor Class (RFTMX)

Ticker RFTMX · · Holdings as of Jul 31, 2026

Expense ratio
1.53%$153/yr per $10k
Net assets
$11.7Mall share classes
Holdings
49

Bottom line

Is RFTMX a good fund? The bottom line

RFTMX is the Investor Class share class of Ranger Micro Cap Fund, an actively managed small-cap mutual fund from Spend Life Wisely.

Annual fees run 1.53% — about $153 a year on every $10,000 invested, more expensive than 87% of small-cap funds we track.

With $11.7 million in net assets and 49 holdings, its largest position is Ligand Pharmaceuticals, Inc. (5.6%) and the top 10 make up 35.3% of the portfolio.

What to watch

  • Expensive for its category (1.53%)
  • 12b-1 marketing fee of 0.25% a year
  • Small fund ($11.7 million) — small funds are likelier to close

Updated Nov 19, 2026

What RFTMX invests in

The Fund seeks long-term capital appreciation.

"Principal Investment Strategies: Under normal market conditions, the Fund invests at least 80% of its assets in common stocks of micro capitalization (""micro cap"") companies. The Micro Cap Growth Strategy seeks long-term growth of capital by investing primarily in common stocks of growth-oriented domestic issuers which, at the initial time of purchase are within the capitalization range of issuers represented within the Russell Microcap Growth Index. As of the most recent reconstitution date of April 30, 2025, the market capitalization range was $30.3 million to $1.3 billion. RIM's strategy begins by narrowing the microcap stock universe to identify companies that RIM believes have a proven track record of competitive advantages and the ability to produce sustainable value for shareholders in the foreseeable future. From this group, RIM selects securities that it believes are…

From the fund's prospectus (filed Dec 1, 2025).

What RFTMX costs

On a $10,000 investment, RFTMX's 1.53% expense ratio costs about $153 a year. The prospectus estimates $2,520 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full RFTMX fee table →

RFTMX top 10 holdings

#Holding% of fund
1Ligand Pharmaceuticals, Inc.5.60%
2PDF Solutions, Inc.4.05%
3Karat Packaging, Inc.4.01%
4The Pennant Group, Inc.3.49%
5Fidelity Institutional Cash Portfolios3.20%
6Business First Bancshares, Inc.3.10%
7Phibro Animal Health Corp3.07%
8iRadimed Corp.3.06%
9Metropolitan Bank Holding Corp.2.94%
10UFP Technologies, Inc.2.79%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 35.3% of the fund. See all top 25 holdings and asset mix →

Alternatives to RFTMX

More funds like RFTMX →

RFTMX FAQ

What is the expense ratio of RFTMX?
RFTMX's expense ratio is 1.53%, which works out to about $153 a year for every $10,000 invested. The prospectus estimates total costs of $2,520 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is RFTMX a good investment?
It depends on your goals, but the data points to: expensive for its category (1.53%); 12b-1 marketing fee of 0.25% a year; small fund ($11.7 million) — small funds are likelier to close. This is general information, not personalized advice.
What does RFTMX hold?
RFTMX's largest holdings are Ligand Pharmaceuticals, Inc. (5.6%), PDF Solutions, Inc. (4.1%), Karat Packaging, Inc. (4.0%), The Pennant Group, Inc. (3.5%), Fidelity Institutional Cash Portfolios (3.2%). It holds 49 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
Who manages RFTMX?
RFTMX is offered by Spend Life Wisely through Spend Life Wisely Funds Investment Trust.